Notable Upgrades: Vertex Pharma (VRTX), AcelRx (ACRX), First Solar (FSLR), LinkedIn (LNKD), Nvidia (NVDA)

Analysts at H.C. Wainwright are out with a report this morning upgrading shares of Vertex Pharmaceuticals Incorporated (VRTX) with a ‘Buy’ from ‘Neutral’ rating. The firm raised its price target for the company to $155 from $85, noting that during the last four months they have witnessed a fundamental change in the company’s pipeline as […] View the full post at: Notable Upgrades: Vertex Pharma (VRTX), AcelRx (ACRX), First Solar (FSLR), LinkedIn (LNKD), Nvidia (NVDA) Related posts: An Opportunity in First Solar? Top Pre-Market Stock Upgrades/Downgrades April 22, 2010 Top Pre-Market Stock Upgrades/Downgrades April 26, 2010